Search for Clinical Trial Results

Sponsored By

DiGeorge Syndrome - 25 Studies Found

Status Study
Active, not recruiting Study Name: Thymus Transplantation in DiGeorge Syndrome #668
Condition:
  • DiGeorge Syndrome
  • Complete Typical DiGeor
    Date: 2007-12-17
    Interventions: Biological: Thymus Tissue for Transplantation Thymus transplantation is done using allogeneic cultured p
Active, not recruiting Study Name: Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Condition:
  • DiGeorge Syndrome
  • 22q11.2 Deletion Syndro
    Date: 2007-11-08
Terminated Study Name: Infection in DiGeorge Following CHD Surgery
Condition:
  • DiGeorge Syndrome
  • Congenital Heart Defects

Date: 2006-01-13
Completed Study Name: Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions
Condition: 22q11.2 Deletion Syndrome
Date: 2016-08-29
Interventions: Drug: NFC-1 Doses of NFC-1 will be administered as 50, 100, 200, or 400 mg twice daily as size 2, hard g
Active, not recruiting Study Name: Parathyroid and Thymus Transplantation in DiGeorge #931
Condition:
  • DiGeorge Syndrome
  • Hypoparathyroidism
  • DiGeorge Anomaly
    Date: 2009-02-22
    Interventions:
    • Biological: Serum Free Thymus Transplantation with Immunosuppression

Recruiting Study Name: Non-Invasive Chromosomal Evaluation of 22q11.2
Condition: DiGeorge Syndrome, Velocardiofacial Syndrome, 22q.11.2 Deletion Syndrome
Date: 2015-09-02
Recruiting Study Name: Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome
Condition:
  • DiGeorge Syndrome
  • Shprintzen Syndrome Date: 2000-04-06
Completed Study Name: Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome
Condition:
  • Immune Defect
  • 22q11.2 Deletion Syndrome

Date: 2015-04-10
Active, not recruiting Study Name: Effects of PTH Replacement on Bone in Hypoparathyroidism
Condition:
  • Hypoparathyroidism
  • DiGeorge Syndrome

Date: 2006-11-02
Interventions: Drug: PTH 1-34 Given twice daily by subcutaneous
Next >>>